COSCIENS Biopharma Inc. (CSCIF) stock
CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
$6.49+0.00 (0.00%)
Close on Oct 19, 2026Market cap $24.10MP/E –Yield –
COSCIENS Biopharma operating margin
Operating margin is operating income as a percentage of revenue.
COSCIENS Biopharma's operating margin for the twelve months ending Mar 31, 2026 was -98.8%. For fiscal 2025 it was -142.5%, against -190.7% the year before. The highest annual figure on record is 36.6% in fiscal 2018.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -142.5% | +48.2 |
| FY2024 | Dec 31, 2024 | -190.7% | −125.9 |
| FY2023 | Dec 31, 2023 | -64.8% | −94.5 |
| FY2022 | Dec 31, 2022 | 29.6% | +194.5 |
| FY2021 | Dec 31, 2021 | -164.8% | −8.6 |
| FY2020 | Dec 31, 2020 | -156.2% | +1768.9 |
| FY2019 | Dec 31, 2019 | -1925.2% | −1961.8 |
| FY2018 | Dec 31, 2018 | 36.6% | +2536.5 |
| FY2017 | Dec 31, 2017 | -2499.9% | +735.7 |
| FY2016 | Dec 31, 2016 | -3235.6% | +3165.2 |
| FY2015 | Dec 31, 2015 | -6400.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -38.7% | +153.0 |
| Q4 FY2025 | Dec 31, 2025 | -135.2% | +57.7 |
| Q3 FY2025 | Sep 30, 2025 | -156.6% | +179.7 |
| Q2 FY2025 | Jun 30, 2025 | -85.6% | +75.1 |
| Q1 FY2025 | Mar 31, 2025 | -191.7% | −103.5 |
| Q4 FY2024 | Dec 31, 2024 | -192.9% | −25.2 |
| Q3 FY2024 | Sep 30, 2024 | -336.3% | −279.4 |
| Q2 FY2024 | Jun 30, 2024 | -160.7% | −80.6 |
| Q1 FY2024 | Mar 31, 2024 | -88.2% | +109.5 |
| Q4 FY2023 | Dec 31, 2023 | -167.7% | −304.1 |
| Q3 FY2023 | Sep 30, 2023 | -56.9% | +143.1 |
| Q2 FY2023 | Jun 30, 2023 | -80.0% | +105.4 |
| Q1 FY2023 | Mar 31, 2023 | -197.7% | +129.8 |
| Q4 FY2022 | Dec 31, 2022 | 136.4% | +331.4 |
| Q3 FY2022 | Sep 30, 2022 | -200.1% | −63.8 |
| Q1 FY2022 | Mar 31, 2022 | -185.4% | −105.8 |
| Q4 FY2021 | Dec 31, 2021 | -327.5% | −274.7 |
| Q3 FY2021 | Sep 30, 2021 | -195.1% | +1164.3 |
| Q2 FY2021 | Jun 30, 2021 | -136.3% | +1979.9 |
| Q1 FY2021 | Mar 31, 2021 | -79.7% | +37.6 |
| Q4 FY2020 | Dec 31, 2020 | -52.8% | +9741.7 |
| Q3 FY2020 | Sep 30, 2020 | -1359.4% | −720.5 |
| Q2 FY2020 | Jun 30, 2020 | -2116.2% | −191.9 |
| Q1 FY2020 | Mar 31, 2020 | -117.2% | +7823.3 |
| Q4 FY2019 | Dec 31, 2019 | -9794.4% | −9576.0 |
| Q3 FY2019 | Sep 30, 2019 | -638.9% | −184.7 |
| Q2 FY2019 | Jun 30, 2019 | -1924.2% | +161.5 |
| Q1 FY2019 | Mar 31, 2019 | -7940.5% | – |
| Q4 FY2018 | Dec 31, 2018 | -218.5% | – |
| Q3 FY2018 | Sep 30, 2018 | -454.1% | – |
| Q2 FY2018 | Jun 30, 2018 | -2085.7% | – |
See a number that looks wrong?